Schrodinger PE Ratio 2019-2024 | SDGR
Current and historical p/e ratio for Schrodinger (SDGR) from 2019 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Schrodinger PE ratio as of May 13, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Schrodinger PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-13 | 23.76 | 0.00 | |
| 2024-12-31 | 19.29 | $-2.57 | 0.00 |
| 2024-09-30 | 18.55 | $-2.34 | 0.00 |
| 2024-06-30 | 19.34 | $-2.68 | 0.00 |
| 2024-03-31 | 27.00 | $-1.88 | 0.00 |
| 2023-12-31 | 35.80 | $0.63 | 56.83 |
| 2023-09-30 | 28.27 | $0.56 | 50.48 |
| 2023-06-30 | 49.92 | $0.86 | 58.05 |
| 2023-03-31 | 26.33 | $0.13 | 202.54 |
| 2022-12-31 | 18.69 | $-2.10 | 0.00 |
| 2022-09-30 | 24.98 | $-2.14 | 0.00 |
| 2022-06-30 | 26.41 | $-2.07 | 0.00 |
| 2022-03-31 | 34.12 | $-1.89 | 0.00 |
| 2021-12-31 | 34.83 | $-1.41 | 0.00 |
| 2021-09-30 | 54.68 | $-1.16 | 0.00 |
| 2021-06-30 | 75.61 | $-0.62 | 0.00 |
| 2021-03-31 | 76.29 | $-0.18 | 0.00 |
| 2020-12-31 | 79.18 | $-0.52 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.765B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.281B | 54.26 |
| Hims & Hers Health (HIMS) | United States | $12.358B | 128.40 |
| Tempus AI (TEM) | United States | $10.796B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 72.09 |
| IRhythm Technologies (IRTC) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $3.055B | 208.83 |
| Enovis (ENOV) | United States | $2.089B | 11.65 |
| Clover Health Investments (CLOV) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.531B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| Omnicell (OMCL) | United States | $1.286B | 22.69 |
| 10x Genomics (TXG) | United States | $1.161B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.515B | 154.00 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.441B | 0.00 |
| TruBridge (TBRG) | United States | $0.395B | 875.67 |
| Claritev (CTEV) | United States | $0.353B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.315B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.212B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.151B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |